Zobrazeno 1 - 1
of 1
pro vyhledávání: '"inhibitorji tirozin kinaz"'
Publikováno v:
Radiology and Oncology, vol. 51, no. 3, pp. 241-251, 2017.
Background: When treating patients with advanced non-small cell lung cancer (NSCLC) with tyrosine kinase inhibitors and chemotherapy, intercalated schedule with time separation between the two classes of drugs should avoid their mutual antagonism. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1857::b463003b2451207e951543839492634a
https://dk.um.si/Dokument.php?id=119945&dn=
https://dk.um.si/Dokument.php?id=119945&dn=